What do Investors Stand to Gain from Australia’s Clinical Trial Landscape?

As healthcare giants scramble to create a COVID-19 vaccine, there is a growing interest in clinical trials and how exactly they work.

Of course, though public interest in clinical trials is rising, this part of the healthcare world has been a lucrative sector for the shrewd investor for years.

Research from Grandview valued the global clinical trials market at a neat US$46.8 billion (roughly A$64 billion) in 2019. Moreover, the market research giant expects the clinical trials sector to grow at a compound annual growth rate (CAGR) of 5.1 per cent until 2027.

The market is currently dominated by the United States, with around a quarter of all trials taking place in the States. Read more…..


Chart of the Day

Icarus TV

Christopher J. Nassetta, President and CEO, Hilton Worldwide & Arne M. Sorenson, President and CEO, Marriott International, Inc., speak with Economic Club president David M. Rubenstein on Thursday, March 20, 2014.

Share This Post

Leave a Reply